- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Simon Horslen, MBChB, FRCPCH
- Professor of Pediatrics
- Director of Pediatric Hepatology, UPMC Children's Hospital of Pittsburgh
Administrative Assistant: Kay Carothers
Simon Horslen MB ChB FRCPCH is a Pediatric Hepatologist and Transplant Physician and is certified in General Pediatric and Gastroenterology by the Medical Royal Colleges in the UK. He is Director of Pediatric Hepatology at UPMC Children’s Hospital of Pittsburgh and is a Professor at the University of Pittsburgh School of Medicine. Dr. Horslen earned his medical degree at the University of Bristol Medical School in England and is a Fellow and Founder Member of the Royal College of Pediatrics and Child Health (UK). He is a fellow of the American Society of Transplantation (AST) and of the American Association for the Study of Liver Disease (AASLD)
Dr. Horslen has worked in the US for the last 23 years initially at the University of Nebraska Medical Center, Omaha, NE and subsequently at Seattle Children’s, Seattle, WA as Director of Hepatology and Medical Director of Solid Organ Transplantation. Clinical and research interests include pediatric liver disease, acute liver failure, and liver and intestine transplantation. He has over 150 publications in the areas of pediatric liver disease, intestinal failure and transplantation. Dr Horslen participates in several multicenter studies including SPLIT (Studies in Pediatric Liver Transplantation), PALF (Pediatric Acute Liver Failure) and ChiLDReN (Children’s Liver Disease Research Network). Dr Horslen is a past-Chair of the UNOS/OPTN Pediatric Committee and has served as a member of the OPTN/UNOS Board of Governors. He has chaired the Pediatric Community of Practice of the American Society of Transplantation (AST), is a past-President of SPLIT (Society of Pediatric Liver Transplantation) and immediate past-President of IRTA (Intestinal Rehabilitation and Transplantation Association).
Professional and Scientific Society Memberships:
- Royal College of Pediatrics and Child Health, 1997-Present
- American Association for the Study, 1999-Present
- American Society of Transplantation, 2000-Present
- North American Society of Pediatric Gastroenterology and Nutrition, 2000-Present
- United Network for Organ Sharing, 2001-Present
- International Pediatric Transplantation Society, 2002-Present
- Society of Pediatric Research, 2003-2009
- Intestinal Rehabilitation and Transplantation Association, 2004-Present
- American Pediatric Society, 2006-Present
- The Transplantation Society, 2017-Present
Education & Training
- MB, ChB, University of Bristol Medical School, United Kingdom, 1984
Selected Publications
Academic and Research Interests
- Pediatric Liver Disease
- Pediatric Liver Transplantation
- Intestine Transplantation
- Inborn errors of live metabolism
- Acute liver failure
Research Grants
75R60220C00011, Scientific Registry of Transplant Recipients (SRTR), 2021-2025, Hennepin Healthcare Research Institute/HRSA (Prime).
U01DK127995/901628-Pittsburgh, Pediatric Acute Liver Failure Immune Response Network (PALF IRN) Treatment for Immune Mediated Pathophysiology (TRIUMPH), 2021-2026, NIH/NIDDK.
U01DK062466, The Pittsburgh Cholestatic Liver Disease Consortium, 2021-2024, NIH/NIDDK.